SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SERINO, Maria Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.548
AS - Asia 3.476
EU - Europa 2.714
SA - Sud America 619
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 13.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.393
SG - Singapore 1.450
CN - Cina 976
IT - Italia 871
BR - Brasile 515
DE - Germania 438
UA - Ucraina 361
HK - Hong Kong 302
TR - Turchia 273
VN - Vietnam 220
GB - Regno Unito 215
PL - Polonia 212
FI - Finlandia 140
SE - Svezia 113
RU - Federazione Russa 86
CA - Canada 77
MX - Messico 66
FR - Francia 50
SM - San Marino 49
AR - Argentina 48
ID - Indonesia 46
NL - Olanda 41
IN - India 39
ZA - Sudafrica 37
ES - Italia 34
JP - Giappone 33
BE - Belgio 25
EC - Ecuador 24
BD - Bangladesh 22
CZ - Repubblica Ceca 22
LT - Lituania 18
IQ - Iraq 17
PK - Pakistan 14
AT - Austria 13
LK - Sri Lanka 11
EG - Egitto 9
IR - Iran 8
KE - Kenya 8
VE - Venezuela 8
CO - Colombia 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
AZ - Azerbaigian 6
MA - Marocco 6
UZ - Uzbekistan 6
IE - Irlanda 5
IL - Israele 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 4
CL - Cile 4
DO - Repubblica Dominicana 4
EU - Europa 4
KR - Corea 4
KZ - Kazakistan 4
NO - Norvegia 4
SA - Arabia Saudita 4
TH - Thailandia 4
AL - Albania 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
LB - Libano 2
NZ - Nuova Zelanda 2
PE - Perù 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
TG - Togo 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.446
Salva come PNG Salva come JPEG
Città #
Singapore 777
Woodbridge 658
Ashburn 636
Fairfield 536
Chandler 484
Jacksonville 407
Beijing 359
Santa Clara 336
Hong Kong 301
Houston 299
Ann Arbor 261
Seattle 236
Wilmington 224
Warsaw 206
Cambridge 157
Izmir 150
Ferrara 129
Munich 128
New York 122
Los Angeles 114
Nanjing 112
Milan 101
Dallas 100
Princeton 86
Boardman 71
Ho Chi Minh City 71
Shanghai 58
Mexico City 47
San Diego 46
São Paulo 45
Hanoi 41
Turku 41
Bremen 38
London 37
Shenyang 34
Jakarta 33
Buffalo 32
Dearborn 32
Tokyo 32
Chicago 31
Hebei 30
Montreal 29
Rome 29
Orem 28
Nanchang 26
Denver 25
Brooklyn 24
Johannesburg 24
Phoenix 24
The Dalles 24
Brussels 23
Changsha 23
Toronto 23
Helsinki 22
Rio de Janeiro 21
Boston 20
Jiaxing 20
Redwood City 20
Düsseldorf 19
Tianjin 18
Stockholm 17
Nuremberg 16
Amsterdam 15
Chennai 15
Curitiba 15
Hefei 15
Jinan 15
Mountain View 15
Naples 15
Bologna 14
Council Bluffs 14
Da Nang 14
Moscow 14
Poplar 14
Brno 13
Falls Church 13
Dong Ket 12
Frankfurt am Main 12
Haiphong 12
Manchester 12
Des Moines 11
Domagnano 11
Guangzhou 11
Meda 11
Atlanta 10
Brasília 10
Colombo 10
Kunming 10
San Francisco 10
Washington 10
Auburn Hills 9
Augusta 9
Charlotte 9
Guayaquil 9
Jackson 9
Napoli 9
São Bernardo do Campo 9
Baghdad 8
Belo Horizonte 8
Orange 8
Totale 8.553
Salva come PNG Salva come JPEG
Nome #
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 553
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 260
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 256
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 244
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 230
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 230
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 210
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 209
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 209
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 208
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 207
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 206
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 203
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 200
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 199
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 197
A photometric assay for factor-XIII in chronic hepatopathies. 188
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 188
Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients 188
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 186
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 184
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 181
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 178
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 176
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 172
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 166
Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation 161
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 160
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 157
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 156
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 154
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 153
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers 153
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities 150
A web-based clinical record 'xl'Emofilia® 'for outpatients with haemophilia and allied disorders in the region of Emilia-Romagna: Features and pilot use 149
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 149
A modified functional global test to measure PC, PS activities and the APC-resistance phenotype 148
Clinical observations on the relationship between idiopathic thrombocytopenic purpura lupus anticoagulant and anticardio-lipin antibody syndrome. 148
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 143
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 142
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 141
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 139
Una "rete" per proteggere il cuore. (FAR 2013) 139
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 137
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 136
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 136
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 135
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 135
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 135
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 134
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: Identification of 23 new mutations 133
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 133
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 132
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 129
Malattie emorragiche vascolari. 128
A Common mutation in the gene for coagulation factor XIII-A (V34L): a risk factor for hemorrhagic disorders it is protective against atherothrombotic diseases. 126
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 126
Anticardiolipin antibody-related thrombocytopenia: persistent remission after splenectomy. 126
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 120
null 118
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 118
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 117
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 113
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 112
Thrombotic risk in thalassemic patients 112
Bassi livelli di Proteina S e Resistenza alla Proteina C attivata in dieci famiglie italiane. 108
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 106
High protein C plasma levels affect the response to exogenous preactivated protein C and enhance that to endogenous Protac-mediated activated protein C. 105
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 104
null 102
Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations 102
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes 101
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 99
DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? 98
MTHFR Specific Activity, Homocysteine and Folate Levels in Subjects with Thermolabile MTHFR (C677T) 97
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 96
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 94
null 91
FXIII-A V34L and FXIII-B H95R gene polymorphism: effects on the efficacy of thrombolytic therapy in acute myocardial infarction. 87
null 85
Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy 84
Genotype and PK Hemophilia B International Study (GePKHIS) - A progress Report 84
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 82
Detection of a Protein C Gene Mutation Present in the Asymptomatic and not in the Thrombosis-Prone Lineage. 81
null 80
Treatment outcome and postoperative complications of mucogingival surgery in a case of type I von Willebrand disease 76
Conteggio piastrinico e terapia sostitutiva in un paziente con Malattia di von Willebrand tipo 2B. 72
Common Factor XIII Gene Polymorphisms In Venous Leg Ulcers. 72
Sui rapporti tra anticorpi anticardiolipina e ß-2-glicoproteina I plasmatica. 69
Piastrinopenia da anticorpi anticardiolipina: remissione persistente dopo splenectomia. 68
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 64
null 61
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 55
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 55
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 53
GRB 130427A: a Nearby Ordinary Monster 52
null 49
Totale 13.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 509
Totale 59.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021768 0 0 0 0 0 139 51 140 46 181 151 60
2021/2022837 30 77 46 41 65 36 37 51 28 86 104 236
2022/20231.093 106 104 21 131 189 156 60 109 111 9 63 34
2023/2024605 53 69 26 26 72 94 28 49 9 21 25 133
2024/20252.456 72 45 175 91 312 188 97 122 467 256 353 278
2025/20263.619 633 262 536 882 945 361 0 0 0 0 0 0
Totale 13.593